MedPath

Effect of Mesenchymal stem cells in patients with decompensated cirrhosis

Phase 1
Conditions
Fibrosis and cirrhosis of liver
Registration Number
RBR-8n8csf
Lead Sponsor
Hospital de Clínicas de Porto Alegre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Data analysis completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

fulfilling ACLF diagnostic criteria and ACLF grade 2 or 3

Exclusion Criteria

patient’s or family member’s refusal; (b) hepatocellular carcinoma (HCC); (c) formal contraindicationfor liver transplantation (e.g. advanced heart or pulmonary disease); (d) pregnancy and lactation; (e) previous liver transplantation; (f) HIV co-infection; (g) ACLF grade 1; (h) patients admitted for elective procedures; (i) renal chronic disease requiring dialysis.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath